STAINER, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 395
EU - Europa 206
AS - Asia 70
AF - Africa 40
SA - Sud America 2
OC - Oceania 1
Totale 714
Nazione #
US - Stati Uniti d'America 392
CN - Cina 50
FI - Finlandia 49
NG - Nigeria 39
IE - Irlanda 33
DE - Germania 26
IT - Italia 23
SE - Svezia 19
FR - Francia 17
MK - Macedonia 13
GB - Regno Unito 9
IN - India 8
PH - Filippine 7
NL - Olanda 4
UA - Ucraina 4
CA - Canada 3
JP - Giappone 3
PL - Polonia 3
CH - Svizzera 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
HR - Croazia 1
IL - Israele 1
NO - Norvegia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
UG - Uganda 1
Totale 714
Città #
Chandler 96
New York 54
Shanghai 50
Helsinki 49
Benin City 39
Boardman 36
Dublin 33
Ashburn 30
Lawrence 24
Princeton 24
Paris 17
Milan 10
London 9
Skopje 8
Pune 7
Sacramento 7
Bitola 5
Frankfurt am Main 5
Leawood 4
Amsterdam 3
Olongapo City 3
Winnipeg 3
Asagayakita 2
Gdansk 2
Henderson 2
Las Pinas 2
Phoenix 2
Sale Marasino 2
Venegono Superiore 2
Cagayan de Oro 1
Canberra 1
Falkenstein 1
Florence 1
Gallarate 1
Heeten 1
Irving 1
Matsuyama 1
Moscow 1
Oslo 1
Riyadh 1
San Mateo 1
Sindelfingen 1
Tandag 1
Tel Aviv 1
Wilmington 1
Zagreb 1
Totale 547
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 109
COVID-19 in Immunocompromised Patients: A Systematic Review 41
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 37
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 33
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 30
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 27
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma 27
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 26
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 26
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 24
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions 24
Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults 24
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 23
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 21
Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 20
Cardiovascular Complications in Community-Acquired Pneumonia 19
Early or delayed bronchoscopy in patients admitted to the emergency department for mild-to-moderate hemoptysis? 19
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 19
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 18
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 18
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 17
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 16
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 16
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 15
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 15
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 14
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 13
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 13
Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview 12
Treatable traits in interstitial lung diseases: a call to action 11
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 10
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 8
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 7
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 7
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 6
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 6
Treatable Traits in Systemic Sclerosis 2
Response to: are there over 200 distinct types of interstitial lung diseases? 2
Walking the path of treatable traits in interstitial lung diseases 1
Long-Term Outcomes in Severe Community-Acquired Pneumonia 1
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 1
Totale 778
Categoria #
all - tutte 7.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022102 0 0 0 1 0 0 1 1 23 42 30 4
2022/2023350 51 11 44 7 37 21 17 29 58 41 27 7
2023/2024315 37 15 66 41 10 72 31 17 18 8 0 0
Totale 778